Histopathological risk factors for malignancy in dermatomyositis

Area of Science:

• Dermatopathology
• Oncology
• Rheumatology

Background:

• Dermatomyositis is an idiopathic inflammatory myopathy associated with an increased risk of malignancy.
• Identifying reliable histopathological markers for malignancy risk in dermatomyositis is crucial for early detection and management.

Purpose of the Study:

• To investigate potential histopathological risk factors for malignancy in skin biopsies from dermatomyositis patients.
• To correlate specific histopathological findings with the presence or absence of associated malignancy.

Main Methods:

• Analysis of clinical metadata and 30 skin biopsies from 23 dermatomyositis patients (11 with malignancy, 12 without).
• Histopathological evaluation using H&E, PAS, Alcian Blue, and anti-CD123 immunohistochemistry.
• Statistical analysis, including odds ratios and confidence intervals, after correcting for multiple testing.

Main Results:

• Biopsies from patients with malignancy showed significantly increased basement membrane thickening and pigment incontinence.
• A higher count of subepidermal melanophages was associated with over a 5-fold increased odds of internal malignancy (OR 5.3, P<0.05).
• A superficial distribution pattern of CD123+ plasmacytoid dendritic cells (PDCs) was observed in the malignancy group (P<0.01).

Conclusions:

• Basement membrane thickening and pigment incontinence are potential histopathological indicators of malignancy risk in dermatomyositis.
• The superficial distribution of CD123+ PDCs may also serve as a predictive marker for malignancy.
• These findings could aid in risk stratification and early detection of cancer in dermatomyositis patients.